ArteraAI Secures $20 Million in Funding to Further Personalize Cancer Therapy With Multimodal AI
The funding will support the international expansion and commercial growth of the company and its first-of-its-kind test February 01, 2024 09:00 AM Eastern Standard Time SAN FRANCISCO–(BUSINESS WIRE)–ArteraAI, the developer of multimodal artificial intelligence (MMAI)…